The anti-apoptotic and anti-inflammatory properties of puerarin attenuate 3-nitropropionic-acid induced neurotoxicity in rats

Mahdy, H.M.; Mohamed, M.R.; emam, Manal; Karim, A.M.; Abdel-Naim, A.; Khalifa, A.E.;

Abstract


Puerarin (Pur), an isoflavonoid extracted from the dried roots of Pueraria lobata, has been reported to be useful in the treatment of various diseases. This study was designed to evaluate the anti-apoptotic and anti-inflammatory activities of Pur against 3-nitropropionic acid (3-NP) induced neurotoxicity. For 5 consecutive days, male Wistar rats were given Pur (200 mg/kg body mass) 30 min before treatment with 20 mg/kg body mass of 3-NP. The striata, hippocampi, and cortices of the 3-NP treated group showed apoptotic damage, inflammation, and energy deficit as well as histopathological lesions. The 3-NP-induced alteration in apoptotic biomarkers (caspase-3 activity/level, cytosolic cytochrome c, Bax/Bcl-2 levels) were significantly ameliorated by Pur treatment. Moreover, Pur pretreatment blocked 3-NP-induced inflammatory biomarkers (NF-κB, TNF-α, and iNOS) and prevented the energy deficit (ATP reduction). Nissl staining further confirmed Pur's neuroprotective effect. These results indicate that Pur may be a useful preventive approach to various neurodegenerative diseases with underlying apoptosis and neuroinflammation.


Other data

Title The anti-apoptotic and anti-inflammatory properties of puerarin attenuate 3-nitropropionic-acid induced neurotoxicity in rats
Authors Mahdy, H.M. ; Mohamed, M.R. ; emam, Manal ; Karim, A.M. ; Abdel-Naim, A. ; Khalifa, A.E. 
Issue Date 2014
Journal Canadian Journal of Physiology and Pharmacology 
DOI 3
252
258
http://www.scopus.com/inward/record.url?eid=2-s2.0-84900380715&partnerID=MN8TOARS
92
10.1139/cjpp-2013-0398
PubMed ID 92
Scopus ID 2-s2.0-84900380715

Recommend this item

Similar Items from Core Recommender Database

Google ScholarTM

Check

Citations 2 in pubmed
Citations 46 in scopus
views 6 in Shams Scholar


Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.